NCT00405366 Sorafenib in Treating Patients Undergoing Surgery for Stage II, Stage III, or Stage IV Kidney Cancer Status COMPLETED Phase EARLY_PHASE1
NCT00403949 A Study of Azelaic Acid (AzA) 15% in Topical Treatment of Mild to Moderate Perioral Dermatitis Status COMPLETED Phase PHASE2
NCT00403793 Hormonal Contraception in Healthy Young Men (P42306)(COMPLETED)(P06057) Status COMPLETED Phase PHASE2
NCT00403767 An Efficacy and Safety Study of Rivaroxaban With Warfarin for the Prevention of Stroke and Non-Central Nervous System Systemic Embolism in Patients With Non-Valvular Atrial Fibrillation Status COMPLETED Phase PHASE3
NCT00402727 Comparison of Sequential IV/PO Moxifloxacin With IV Piperacillin/Tazobactam Followed by PO Amoxicillin/Clavulanic Acid in Patients With a Complicated Skin and Skin Structure Infection Status COMPLETED Phase PHASE3
NCT00402597 Rivaroxaban in Combination With Aspirin Alone or With Aspirin and a Thienopyridine in Patients With Acute Coronary Syndromes (The ATLAS ACS TIMI 46 Trial) Status COMPLETED Phase PHASE2
NCT00402467 An Oral, Direct Factor Xa Inhibitor, BAY59-7939, for Prophylaxis Against Venous Thromboembolism After Total Knee Replacement: a Dose-Ranging Study Status COMPLETED Phase PHASE2
NCT00398905 Dose-Ranging Study of BAY 59-7939 on the Prevention of VTE in Patients Undergoing Elective Total Hip Replacement Status COMPLETED Phase PHASE2
NCT00396786 Dose-ranging Study of Once-daily Regimen of BAY 59-7939 in the Prevention of VTE in Patients Undergoing Elective Total Hip Replacement Status COMPLETED Phase PHASE2
NCT00395772 Once-daily Oral Direct Factor Xa Inhibitor BAY59-7939 in Patients With Acute Symptomatic Deep-vein Thrombosis Status COMPLETED Phase PHASE2
NCT00395733 Efficacy and Safety Study to Evaluate Gadavist (Gadobutrol) as Contrast Agent in Magnetic Resonance Imaging (MRI) of Vascular Diseases in Chinese Patients Status COMPLETED Phase PHASE3
NCT00395460 Efficacy and Safety Study to Evaluate Gadavist (Gadobutrol) as Contrast Agent in Magnetic Resonance Imaging (MRI) of Brain or Spine Diseases in Chinese Patients Status COMPLETED Phase PHASE3
NCT00393198 Bleeding Pattern and User Satisfaction During Second Consecutive MIRENA® in Contraception and Treatment of Menorrhagia Status COMPLETED Phase PHASE4
NCT00392821 Dosing and Effectiveness Study of Sorafenib and RAD001 in the Treatment of Patients With Advanced Kidney Cancer Status COMPLETED Phase PHASE1/PHASE2
NCT00390611 Paclitaxel and Carboplatin With Or Without Sorafenib In The First-Line Treatment Of Patients With Ovarian Cancer Status COMPLETED Phase PHASE2
NCT00386321 Yt90 Zevalin and Combination Chemotherapy (Z-CHOP)in Treating Patients With Stage II, Stage III, or Stage IV Diffuse Large B-cell Lymphoma Status TERMINATED Phase PHASE2
NCT00381004 FCR Plus Sargramostim (GM-CSF) as Frontline Therapy for Symptomatic Chronic Lymphocytic Leukemia Status COMPLETED Phase PHASE2
NCT00377793 Levitra (Vardenafil, BAY38-9456) Partner Satisfaction Study II Status COMPLETED Phase PHASE4
NCT00376077 A Randomized Study of IVIG vs. IVIG With High Dose Methylprednisolone in Childhood ITP. Status COMPLETED Phase PHASE3